Xiaolin Sang

501 total citations
12 papers, 372 citations indexed

About

Xiaolin Sang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaolin Sang has authored 12 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaolin Sang's work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers) and Advanced Breast Cancer Therapies (2 papers). Xiaolin Sang is often cited by papers focused on MicroRNA in disease regulation (3 papers), RNA modifications and cancer (2 papers) and Advanced Breast Cancer Therapies (2 papers). Xiaolin Sang collaborates with scholars based in China, Japan and United States. Xiaolin Sang's co-authors include Zhi Hong, Mengxi Jiang, Pixu Liu, Hailing Cheng, Zhiwei Tao, Chen‐Yu Zhang, Ke Zen, Dongxia Hou, Fuwen Luo and Min Wang and has published in prestigious journals such as Biomaterials, Oncogene and Cancer Letters.

In The Last Decade

Xiaolin Sang

12 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaolin Sang China	10	224	156	66	62	43	12	372
Zhengang Sun China	9	295 1.3×	96 0.6×	77 1.2×	23 0.4×	25 0.6×	17	561
Takako Takanami Japan	13	335 1.5×	57 0.4×	47 0.7×	103 1.7×	20 0.5×	18	523
Peili Zhang China	14	378 1.7×	166 1.1×	30 0.5×	28 0.5×	18 0.4×	24	560
Zhonglei Lu China	11	240 1.1×	44 0.3×	133 2.0×	28 0.5×	49 1.1×	21	361
Noah Jenkins United States	8	223 1.0×	48 0.3×	66 1.0×	15 0.2×	22 0.5×	8	445
Yuyang Li China	12	275 1.2×	113 0.7×	50 0.8×	21 0.3×	25 0.6×	35	387
Erzsébet Szabó Hungary	10	266 1.2×	67 0.4×	37 0.6×	28 0.5×	32 0.7×	27	424
Abraham Q. Kohrman United States	6	216 1.0×	60 0.4×	69 1.0×	29 0.5×	17 0.4×	8	332
Qingtao Yan China	11	211 0.9×	67 0.4×	78 1.2×	60 1.0×	17 0.4×	20	339

Countries citing papers authored by Xiaolin Sang

Since Specialization

Citations

This map shows the geographic impact of Xiaolin Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Sang more than expected).

Fields of papers citing papers by Xiaolin Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Sang. The network helps show where Xiaolin Sang may publish in the future.

Co-authorship network of co-authors of Xiaolin Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Sang. A scholar is included among the top collaborators of Xiaolin Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Sang. Xiaolin Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Sang, Xiaolin, et al.. (2024). SGK1 suppresses ferroptosis in ovarian cancer via NRF2-dependent and -independent pathways. Oncogene. 43(45). 3335–3347. 4 indexed citations

Wang, Min, Xiaolin Sang, Pixu Liu, et al.. (2022). Phenethyl Isothiocyanate Enhances the Cytotoxic Effects of PARP Inhibitors in High-Grade Serous Ovarian Cancer Cells. Frontiers in Oncology. 11. 812264–812264. 9 indexed citations

Zhang, Yuan, Xiang Gao, Xiaolin Sang, et al.. (2021). BTF3 confers oncogenic activity in prostate cancer through transcriptional upregulation of Replication Factor C. Cell Death and Disease. 12(1). 12–12. 17 indexed citations

Sang, Xiaolin, Min Wang, Yichao Liu, et al.. (2021). Melatonin potentiates the cytotoxic effect of Neratinib in HER2+ breast cancer through promoting endocytosis and lysosomal degradation of HER2. Oncogene. 40(44). 6273–6283. 27 indexed citations

Sang, Xiaolin, Li Li, Yichao Liu, et al.. (2021). Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer. Cancer Letters. 518. 82–93. 20 indexed citations

Zhang, Shuo, Xiaolin Sang, Dongxia Hou, et al.. (2019). Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg. Biomaterials. 210. 83–93. 29 indexed citations

Wang, Min, Pan Qin, Xiaolin Sang, et al.. (2019). Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer. Redox Biology. 24. 101225–101225. 26 indexed citations

Tao, Zhiwei, Min Wang, Xiaolin Sang, et al.. (2019). MYC status as a determinant of synergistic response to Olaparib and Palbociclib in ovarian cancer. EBioMedicine. 43. 225–237. 58 indexed citations

Hou, Dongxia, Fangfang He, Lina Ma, et al.. (2018). The potential atheroprotective role of plant MIR156a as a repressor of monocyte recruitment on inflamed human endothelial cells. The Journal of Nutritional Biochemistry. 57. 197–205. 83 indexed citations

10.

Wang, Xiaonan, Yuan Zhang, Xiaolin Sang, et al.. (2018). Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα. Cancer Letters. 440-441. 54–63. 26 indexed citations

11.

Sang, Xiaolin, Shin’ichi Warisawa, Hao Zhang, et al.. (2015). Detection of Drug Administration Behavior with Swallowing Sounds. 367–373. 1 indexed citations

12.

Jiang, Mengxi, Xiaolin Sang, & Zhi Hong. (2012). Beyond nutrients: Food‐derived microRNAs provide cross‐kingdom regulation. BioEssays. 34(4). 280–284. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact